Dexmedetomidine Supplemented Analgesia and Delirium After Hip Fracture Surgery
Impact of Dexmedetomidine Supplemented Analgesia on Delirium and Long-term Outcomes in Elderly After Hip Fracture Surgery: A Multicenter, Double-blinded, Randomized Controlled Trial
Sponsor: Peking University First Hospital
Terminated
Stopped prematurely because of too few cases.
Other terminated trials from Peking University First Hospital
Other Dexmedetomidine trials with similar outcome
Listed as NCT04955249, this PHASE4 trial focuses on Dexmedetomidine and Elderly and remains terminated or withdrawn. Sponsored by Peking University First Hospital, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE4
▶ Show 1 earlier version
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University First Hospital
For direct contact, visit the study record on ClinicalTrials.gov .